7. Pickard, J.D., et al., Steps towards cost-benefit analysis of regional neurosurgical care. Br Med J, 1990. 301(6753): p. 629-635. 8. Ekman, M. and M. Westphal, Cost of brain tumour in Europe. Eur J Neurol, 2005. 12: p. 45-9. 9. Imperato, J.P., N.A. Paleologos, and N.A. Vick, Effects of treatment on long -term survivors with malignant astrocytomas. Ann Neurol, 1990. 28(6): p. 818-822. 10. Hall, W.A. and O. Fodstad, Immunotoxins and central nervous system neoplasia. J Neurosurg, 1992. 76(1): p. 1 -12. 11. Banchereau, J. and R.M. Steinman, Dendritic cells and the control of immunity. Nature, 1998. 392(6673): p. 245-52. 12. Steinman, R.M., Dendritic cells and the control of immunity: enhancing the efficiency of antigen presentation. Mount Sinai Journal of Medicine, 2001. 68(3): p. 106-66. 13. Fujii, S., et al., Analysis of a chronic myelogenous leukemia patient vaccinated with leukemic dendritic cells following autologous peripheral blood stem cell transplantation. Japanese Journal of Cancer Research, 1999. 90 (10): p. 1117-29.